1. Fullerton, Morgan D, Hakimuddin, Fatima, Bakovic, Marica. 2007. Developmental and metabolic effects of disruption of the mouse CTP:phosphoethanolamine cytidylyltransferase gene (Pcyt2). In Molecular and cellular biology, 27, 3327-36. doi:. https://pubmed.ncbi.nlm.nih.gov/17325045/
2. Vaz, Frédéric M, McDermott, John H, Alders, Mariëlle, Engelen, Marc, Banka, Siddharth. . Mutations in PCYT2 disrupt etherlipid biosynthesis and cause a complex hereditary spastic paraplegia. In Brain : a journal of neurology, 142, 3382-3397. doi:10.1093/brain/awz291. https://pubmed.ncbi.nlm.nih.gov/31637422/
3. Zhou, Lian, Zhang, Su, Wang, Lingli, Wen, Linda, Han, Junhong. 2024. PCYT2 inhibits epithelial-mesenchymal transition in colorectal cancer by elevating YAP1 phosphorylation. In JCI insight, 9, . doi:10.1172/jci.insight.178823. https://pubmed.ncbi.nlm.nih.gov/39531326/
4. Zhu, Lin, Bakovic, Marica. 2008. Liver X Receptor Agonists Inhibit the Phospholipid Regulatory Gene CTP: Phosphoethanolamine Cytidylyltransferase-Pcyt2. In Research letters in biochemistry, 2008, 801849. doi:10.1155/2008/801849. https://pubmed.ncbi.nlm.nih.gov/22820672/
5. Zhu, Lin, Michel, Vera, Bakovic, Marica. 2009. Regulation of the mouse CTP: phosphoethanolamine cytidylyltransferase gene Pcyt2 during myogenesis. In Gene, 447, 51-9. doi:10.1016/j.gene.2009.07.014. https://pubmed.ncbi.nlm.nih.gov/19646513/
6. Singh, Ratnesh Kumar, Fullerton, Morgan D, Vine, Donna, Bakovic, Marica. 2012. Mechanism of hypertriglyceridemia in CTP:phosphoethanolamine cytidylyltransferase-deficient mice. In Journal of lipid research, 53, 1811-22. doi:10.1194/jlr.M021881. https://pubmed.ncbi.nlm.nih.gov/22764088/
7. Osawa, Tsuyoshi, Shimamura, Teppei, Saito, Kyoko, Soga, Tomoyoshi, Kodama, Tatsuhiko. . Phosphoethanolamine Accumulation Protects Cancer Cells under Glutamine Starvation through Downregulation of PCYT2. In Cell reports, 29, 89-103.e7. doi:10.1016/j.celrep.2019.08.087. https://pubmed.ncbi.nlm.nih.gov/31577958/
智鼠故事 
